BAM
RETA

Belpointe Asset Management’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Belpointe Asset Management’s Portfolio RETA Stock Details RETA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-311
Closed -$28.3K – 3653
2023
Q1 		$28.3K Buy
311
+219
+238% +$19.9K ﹤0.01% 2094
2022
Q4 		$3.5K Buy
+92
New +$3.5K ﹤0.01% 3058